Related Experiment Video
Updated: Jun 28, 2026

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025
The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural
1LEC, Lancaster University, Bailrigg, Lancaster LA1 4YQ, UK. f.martin@lancaster.ac.uk
Abstract:
Cambridge Health Tech Institute's first conference on 'The Future of Cancer Diagnostics: Next Generation Molecular Technologies' covered the following areas: regulatory requirements regarding the validation of new cancer diagnostics; how such validation processes might be suitably implemented from laboratory to clinical pipeline to the bedside; translational strategies, such as proteomics or methylation patterns; and novel biomarkers in oncology. Overall in this golden age of cancer research, the aims and objectives of the meeting were to explore how the implementation of new diagnostic strategies could be facilitated. This meeting examined various topics, including 'Early cancer detection', 'Differential diagnosis', 'Prognostic markers and therapy selection' and 'Circulating tumor cells'. The talks and sessions of the meeting are summarized in this report, with particular focus on preclinical and clinical therapies.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer